… ,systematic evaluation/meta-analysis and economic evaluations about Aidi injection combined
with first-line chemotherapy for … ,2 pieces of pharmacoeconomic studies. Compared with …

… of OP treatment drugs and further affect the results of pharmacoeconomic evaluations.
Therefore, … alone after completion of chemotherapy with bevacizumab for first-line treatment of …

… Pharmacoeconomic evaluation of osimertinib in the first-line … Compared with erlotinib,
gefitinib, afatinib and icotinib, osimertinib was more cost-effective as the first-line treatment for …

… to evaluate the accuracy of the nomogram model in predicting the prognosis of patients with
EGFR mutation-positive NSCLC treated … receiving first-line gefitinib or erlotinib treatment[J].…

… BIA research paradigms or evaluating standards so as to guide … Budget impact of erlotinib
for maintenance therapy in ad… arterial disease:a systematic review and budget impact model …

… ABSTRACT OBJECTIVE:To evaluate the economics of … -generation EGFR-TKIs in first-line
treatment of locally advanced or … :a systematic analysis for the global burden of disease study …

… is to review the progress in basic and clinical research on molecular targeted therapy for …
Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie …